Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats.

Bimoclomol (BRLP-42) is a novel antiischemic compound acting against peripheral vascular complications of diabetes mellitus (neuropathy, retinopathy, and nephropathy). In the present study the activity of bimoclomol was tested in experimental subarachnoid hemorrhage (SAH) and arachidonic acid (AA)-i...

Teljes leírás

Bibliográfiai részletek
Szerzők: Erdő Franciska
Erdo SL
Dokumentumtípus: Cikk
Megjelent: 1998
Sorozat:BRAIN RESEARCH BULLETIN 45 No. 2
Tárgyszavak:
doi:10.1016/S0361-9230(97)00333-X

mtmt:2802864
Online Access:https://publikacio.ppke.hu/2337

Hasonló tételek